ENTA logo

Enanta Pharmaceuticals, Inc. (ENTA)

Profile

Full Name

Enanta Pharmaceuticals, Inc.

Ticker

NASDAQ: ENTA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 21, 2013

Indexes

Not included

Website

https://www.enanta.com

Employees

131

Key Details

Price

$12.13(-1.86%)

Market Cap

$349.99M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$65.32M(-3.42% YoY)

Annual EPS

-$3.84(30.03% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $12.13
    ENTA price is $12.13

    30-Day Relative Volume

    0.60
    ENTA 30-day relative volume is 0.60

    Price Performance

    Price Most Recent Change

    -1.86%
    ENTA price was down -1.86% on Nov 19, 2025

    Price YTD Change

    +110.96%
    ENTA price is up +110.96% since January 1st

    Price 1-Year Change

    +28.77%
    ENTA price is up +28.77% year-on-year

    Price 3-Year Change

    -74.09%
    ENTA price is down -74.09% over the past 3 years

    Price Range

    Price All-Time High

    $127.77
    ENTA price is currently -90.51% below its historical high of $127.77

    Price 3-Year Low

    $4.09
    ENTA price is currently +196.58% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $349.99M
    ENTA market cap is $349.99 million

    Market Cap 3-Year Change

    -64.06%
    ENTA market cap is down -64.06% over the past 3 years

    Market Cap All-Time High

    $2.45B
    ENTA market cap is currently -85.69% below its historical high of $2.45 billion

    Market Cap Sector Percentile

    57.66%
    ENTA market cap is higher than 57.66% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +36.14%
    ENTA shares outstanding is up +36.14% year-on-year

    Shares Outstanding 3-Year Change

    +38.73%
    ENTA shares outstanding is up +38.73% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.89
    ENTA beta is 0.89

    200-day SMA

    $7.71
    ENTA price is currently +57.26% above its 200-day simple moving average

    50-day SMA

    $10.45
    ENTA price is currently +16.09% above its 50-day simple moving average

    14-Day RSI

    59.56
    ENTA 14-day relative strength index is 59.56

    Volume

    0.60
    ENTA 30-day relative volume is 0.60

    ATR

    $0.85
    ENTA average true range is $0.85

    10-day Historical Volatility

    53.95%
    ENTA 10-day historical volatility is 53.95%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $65.32M
    ENTA annual revenue is $65.32 million

    Revenue Analysts Estimate

    $64.55M
    ENTA annual revenue is currently +1.21% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -3.42%
    ENTA annual revenue is down -3.42% year-on-year

    Revenue Sector Percentile

    65.01%
    ENTA annual revenue is higher than 65.01% of companies in Healthcare sector

    EPS

    EPS

    -$3.84
    ENTA annual earnings per share is -$3.84

    EPS Analysts Estimate

    -$3.27
    ENTA annual earnings per share is currently -17.22% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +30.03%
    ENTA annual earnings per share is up +30.03% year-on-year

    EPS Sector Percentile

    24.94%
    ENTA annual earnings per share is higher than 24.94% of companies in Healthcare sector

    Profit

    Gross Profit

    $0.00
    ENTA annual gross profit is $0.00

    Gross Margin

    0.00%
    ENTA annual gross profit margin is 0.00%

    Operating Profit

    -$85.35M
    ENTA annual operating income is -$85.35 million

    Operating Margin

    -130.65%
    ENTA annual operating profit margin is -130.65%

    Net Income

    -$81.89M
    ENTA annual net profit is -$81.89 million

    Net Margin

    -125.36%
    ENTA annual net profit margin is -125.36%

    Expenses

    Total Expenses

    $147.21M
    ENTA annual total expenses is $147.21 million

    Operating Expenses

    $85.35M
    ENTA annual total operating expenses is $85.35 million

    Cost Of Goods Sold

    -
    ENTA annual cost of goods sold value is unknown

    Selling, General & Administrative Expenses

    $0.00
    ENTA annual SG&A is $0.00

    Depreciation & Amortization

    -
    ENTA annual D&A value is unknown

    Interest Expense

    $0.00
    ENTA annual interest expense is $0.00

    Income Tax

    -$1.66M
    ENTA annual income tax is -$1.66 million

    EBIT & EBITDA

    EBIT

    -$85.35M
    ENTA annual earnings before interest & taxes is -$85.35 million

    EBITDA

    -
    ENTA annual EBITDA value is unknown

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $280.73M
    ENTA annual total assets is $280.73 million

    Non Current Assets

    $76.40M
    ENTA annual long term assets is $76.40 million

    Current Assets

    $204.34M
    ENTA annual total current assets is $204.34 million

    Cash and Cash Equivalents

    $188.86M
    ENTA annual cash & cash equivalents is $188.86 million

    Accounts Receivable

    $6.88M
    ENTA annual accounts receivable is $6.88 million

    Inventory

    -
    ENTA annual inventory value is unknown

    Liabilities

    Total Liabilities

    $216.01M
    ENTA annual total liabilities is $216.01 million

    Long Term Liabilities

    $167.46M
    ENTA annual total long term liabilities is $167.46 million

    Current Liabilities

    $48.55M
    ENTA annual current liabilities is $48.55 million

    Accounts Payable

    $1.95M
    ENTA annual accounts payable is $1.95 million

    Debt

    Total Debt

    $201.06M
    ENTA annual total debt is $201.06 million

    Total Debt 1-Year Change

    -11.06%
    ENTA annual total debt is down -11.06% year-on-year

    Long Term Debt

    $167.20M
    ENTA annual long term debt is $167.20 million

    Short Term Debt

    $33.86M
    ENTA annual short term debt is $33.86 million

    Equity & Capital

    Shareholders Equity

    $64.72M
    ENTA annual stockholders equity is $64.72 million

    Book Value

    $64.72M
    ENTA annual book value is $64.72 million

    Retained Earnings

    -
    ENTA annual retained earnings value is unknown

    Working Capital

    $155.78M
    ENTA annual working capital is $155.78 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -
    ENTA annual cash from operations value is unknown

    Cash From Operations 1-Year Change

    -
    ENTA annual cash from operations 1-year change is unknown

    Cash From Investing

    -
    ENTA annual cash from investing value is unknown

    Cash From Investing 1-Year Change

    -
    ENTA annual cash from investing 1-year change is unknown

    Cash From Financing

    -
    ENTA annual cash from financing value is unknown

    Cash From Financing 1-Year Change

    -
    ENTA annual cash from financing 1-year change is unknown

    CAPEX

    CAPEX

    -
    ENTA annual capital expenditures value is unknown

    CAPEX 1-Year Change

    -
    ENTA annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free Cash Flow

    -
    ENTA annual free cash flow value is unknown

    Free Cash Flow 1-Year Change

    -
    ENTA annual free cash flow 1-year change is unknown

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    0.00%
    ENTA annual gross profit margin is 0.00%

    Operating Margin

    -130.65%
    ENTA annual operating profit margin is -130.65%

    Net Margin

    -125.36%
    ENTA annual net profit margin is -125.36%

    ROA & ROE

    ROA

    -24.39%
    ENTA annual return on assets is -24.39%

    ROE

    -84.63%
    ENTA annual return on equity is -84.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ENTA price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ENTA price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.41
    ENTA price to book ratio is 5.41

    PB Ratio Sector Percentile

    79.19%
    ENTA price to book ratio is higher than 79.19% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    5.36
    ENTA price to sales ratio is 5.36

    PS Ratio Sector Percentile

    58.7%
    ENTA price to sales ratio is higher than 58.7% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $362.18M
    ENTA enterprise value is $362.18 million

    Enterprise Value Sector Percentile

    60.41%
    ENTA enterprise value is higher than 60.41% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    ENTA EV/EBITDA value is unknown

    EV/EBITDA Sector Percentile

    -
    ENTA EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.21
    ENTA annual current ratio is 4.21

    Quick Ratio

    -
    ENTA annual quick ratio value is unknown

    Leverage

    Debt To Equity

    3.11
    ENTA annual debt to equity ratio is 3.11

    Interest Coverage Ratio

    -
    ENTA annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    ENTA piotroski f-score value is unknown

    Altman Z-Score

    -
    ENTA altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Nov 14, 25 JP Morgan
    Overweight
    Oct 1, 25 Jefferies
    Buy
    Sep 30, 25 WestPark Capital
    Buy
    Sep 15, 25 Evercore ISI Group
    Outperform
    Sep 2, 25 WestPark Capital
    Buy
    Aug 12, 25 JMP Securities
    Market Outperform
    Jun 3, 25 JMP Securities
    Market Outperform
    May 14, 25 JMP Securities
    Market Outperform
    Feb 11, 25 JMP Securities
    Market Outperform
    Feb 11, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with ENTA included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Enanta Pharmaceuticals, Inc.?
    • Does Enanta Pharmaceuticals, Inc. pay dividends?
    • What sector is Enanta Pharmaceuticals, Inc. in?
    • What industry is Enanta Pharmaceuticals, Inc. in?
    • What country is Enanta Pharmaceuticals, Inc. based in?
    • When did Enanta Pharmaceuticals, Inc. go public?
    • Is Enanta Pharmaceuticals, Inc. in the S&P 500?
    • Is Enanta Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Enanta Pharmaceuticals, Inc. in the Dow Jones?
    • When was Enanta Pharmaceuticals, Inc.'s last earnings report?
    • When does Enanta Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Enanta Pharmaceuticals, Inc.?

    The ticker symbol for Enanta Pharmaceuticals, Inc. is NASDAQ:ENTA

    Does Enanta Pharmaceuticals, Inc. pay dividends?

    No, Enanta Pharmaceuticals, Inc. does not pay dividends

    What sector is Enanta Pharmaceuticals, Inc. in?

    Enanta Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Enanta Pharmaceuticals, Inc. in?

    Enanta Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Enanta Pharmaceuticals, Inc. based in?

    Enanta Pharmaceuticals, Inc. is headquartered in United States

    When did Enanta Pharmaceuticals, Inc. go public?

    Enanta Pharmaceuticals, Inc.'s initial public offering (IPO) was on March 21, 2013

    Is Enanta Pharmaceuticals, Inc. in the S&P 500?

    No, Enanta Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Enanta Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Enanta Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Enanta Pharmaceuticals, Inc. in the Dow Jones?

    No, Enanta Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Enanta Pharmaceuticals, Inc.'s last earnings report?

    Enanta Pharmaceuticals, Inc.'s most recent earnings report was on November 17, 2025

    When does Enanta Pharmaceuticals, Inc. report earnings?

    The date for Enanta Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page